Expected Moves

Mexedia is projected to release H1 2026 results. Investors will scrutinize the print to see if the catastrophic 89.77% YoY revenue collapse has stabilized.

Given the negative free cash flow profile and high debt relative to its $20.5M market cap, Mexedia faces a near-term catalyst for debt restructuring or a highly dilutive equity offering.

Full-year 2026 earnings release and forward guidance. The primary focus will be on whether the company has successfully executed a strategic pivot or faces delisting pressures.